In a bid to curb the misuse of Pregabalin, a drug reported to have narcotic and psychoactive properties, DC Sakshi Sawhney has issued an order extending the ban on the sale of capsules or tablets exceeding 75 mg.
According to the order, Pregabalin, often prescribed by doctors to treat various medical conditions, including neuropathic pain and epilepsy, has been linked to widespread abuse and addiction. The order, issued under Section 163 of BNS, prohibits the sale of Pregabalin above 75 mg without a valid prescription. Wholesalers, retailers, chemists and pharmacies have been prohibited from selling Pregabalin above 75 mg without a prescription. As per the order, only 75 mg of Pregabalin can be prescribed by neurologists and orthopaedists. Accurate records of purchase and sale of up to 75 mg Pregabalin must be maintained. The order will remain in force until April 6, 2025.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now